In – Silico Biological Evaluation of Anticancer Drugs - SWISS ADME
Nizamuddin ND, D Roopa, Pramodini Alla, Afshin Shams Shaik, Vamshi Kumar Achari P, Sudhakar Reddy Kapu · Future Journal of Pharmaceuticals and Health Sciences · 2024
The aim of the present work is to prepare anti - cancer drugs through In – Silico Biological Evaluation using SWISS ADME. The new Swiss ADME web tool, which includes in - house expert methods like the BOILED - Egg, Ilogp, and Bioavailability Radar, provides free access to a pool of quick yet reliable predictive models for physicochemical p roperties, pharmacokinetics, drug - likeness, and medicinal chemistry friendliness. It is developed to predict various pharmacodynamics and pharmacokinetics properties of small mo lecules, helping researchers in the drug discovery and development process. Researchers can use this tool to assess the potential success of a drug in terms of its ADME. Swiss ADME offers predictive model for various pharmacokinetic properties such as solu bility, lipophilicity, and bioavailability this helps researchers assess how a drug candidate will be absorbed, distributed, metabolized, and excreted in the body.